Company profile for Effector Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Effector Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs). Translation is the process in cells whereby the synthesis of proteins is directed by information contained in genetic sequences. Each of our product candidates is designed to act on a single protein that regulates, in a coordin...
Effector Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs). Translation is the process in cells whereby the synthesis of proteins is directed by information contained in genetic sequences. Each of our product candidates is designed to act on a single protein that regulates, in a coordinated manner, the expression of multiple functionally related proteins that together drive tumor cell proliferation and survival, and important biological processes such as immune, stress and inflammatory responses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11180 Roselle Street San Diego, CA 92121
Telephone
Telephone
858-925-8215
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Effector Therapeutics Winds Down After Mid-Stage Oncology Fail
Effector Therapeutics Winds Down After Mid-Stage Oncology Fail

24 Jun 2024

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/end-effector-therapeutics-oncology-biotech-winds-down-after-mid-stage-fail

Annalee Armstrong FIERCE BIOTECH
24 Jun 2024

https://www.globenewswire.com/news-release/2024/05/09/2879129/0/en/eFFECTOR-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
09 May 2024

https://www.globenewswire.com/news-release/2024/04/09/2859911/0/en/eFFECTOR-Therapeutics-to-Participate-in-Upcoming-Investor-Conference.html

GLOBENEWSWIRE
09 Apr 2024

https://endpts.com/effectors-lead-nsclc-program-falls-through-stock-crashes/

Lei Lei Wu ENDPTS
04 Apr 2024

https://www.globenewswire.com/news-release/2024/03/25/2851978/0/en/eFFECTOR-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
25 Mar 2024

https://www.globenewswire.com//news-release/2024/02/05/2823517/0/en/eFFECTOR-Therapeutics-to-Present-at-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html

GLOBENEWSWIRE
05 Feb 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty